Yafang Zhang Selected Research

Vascular Endothelial Growth Factor C

12/2019	Long Noncoding RNA ASLNC07322 Functions in VEGF-C Expression Regulated by Smad4 during Colon Cancer Metastasis.
11/2017	SCARA5 plays a critical role in the progression and metastasis of breast cancer by inactivating the ERK1/2, STAT3, and AKT signaling pathways.
9/2017	Smad4 Inhibits VEGF-A and VEGF-C Expressions via Enhancing Smad3 Phosphorylation in Colon Cancer.
9/2014	microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
4/2012	Correlations between SUVmax and expression of GLUT1 and growth factors inducing lymphangiogenesis.
11/2011	Roles of VEGF-C and Smad4 in the lymphangiogenesis, lymphatic metastasis, and prognosis in colon cancer.
10/2011	RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
9/2011	COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer.
5/2010	Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer.
5/2009	Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yafang Zhang Research Topics

Disease

25	Neoplasms (Cancer) 01/2022 - 10/2008
9	Lymphatic Metastasis 11/2017 - 10/2008
8	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2009
6	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2011
4	Inflammation (Inflammations) 06/2022 - 01/2021
4	Colonic Neoplasms (Colon Cancer) 12/2019 - 11/2011
3	Hypertension (High Blood Pressure) 06/2022 - 10/2009
3	Melanoma (Melanoma, Malignant) 01/2022 - 10/2008
3	Opioid-Related Disorders (Opiate Addiction) 12/2021 - 01/2020
3	Prostatic Neoplasms (Prostate Cancer) 06/2019 - 01/2018
3	Colorectal Neoplasms (Colorectal Cancer) 10/2017 - 02/2009
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2014 - 05/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 01/2018
2	Insulin Resistance 01/2022 - 05/2021
2	Infections 01/2022 - 03/2020
2	Non-alcoholic Fatty Liver Disease 01/2022 - 05/2021
2	Mitochondrial Diseases (Mitochondrial Disease) 05/2021 - 01/2021
2	Virus Diseases (Viral Diseases) 01/2021 - 03/2020
2	Triple Negative Breast Neoplasms 01/2021 - 01/2021
2	Burns 07/2017 - 05/2013
2	Corneal Neovascularization 07/2017 - 05/2013
2	Lung Neoplasms (Lung Cancer) 10/2011 - 09/2011
2	Carcinoma (Carcinomatosis) 04/2009 - 02/2009
1	Memory Disorders (Memory Loss) 09/2022
1	Endotoxemia 07/2022
1	Dysbiosis 07/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 06/2022
1	Brain Ischemia (Cerebral Ischemia) 06/2022
1	Reperfusion Injury 06/2022
1	Atherosclerosis 06/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	COVID-19 12/2021
1	Substance-Related Disorders (Drug Abuse) 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2021

Drug/Important Bio-Agent (IBA)

11	Vascular Endothelial Growth Factor CIBA 12/2019 - 10/2008
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2017 - 04/2009
6	Pharmaceutical PreparationsIBA 09/2022 - 11/2009
6	Long Noncoding RNAIBA 01/2022 - 02/2017
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2014
6	Proteins (Proteins, Gene)FDA Link 09/2017 - 02/2009
5	MicroRNAs (MicroRNA)IBA 12/2020 - 09/2014
5	Messenger RNA (mRNA)IBA 09/2017 - 02/2009
4	Vascular Endothelial Growth Factor DIBA 12/2016 - 10/2008
4	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 09/2014 - 10/2008
2	forsythiasideIBA 07/2022 - 01/2021
2	LipopolysaccharidesIBA 07/2022 - 03/2020
2	AntioxidantsIBA 06/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	neuropeptide Y2 receptorIBA 12/2021 - 01/2021
2	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2021 - 01/2020
2	MicellesIBA 05/2021 - 05/2021
2	Cocaine (Cocaine HCl)IBA 01/2021 - 01/2021
2	crocinIBA 01/2021 - 01/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 09/2011
2	Biological ProductsIBA 11/2017 - 10/2011
2	AlkaliesIBA 07/2017 - 05/2013
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2014 - 05/2010
2	Small Interfering RNA (siRNA)IBA 09/2011 - 05/2009
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2009 - 10/2008
1	Nicotine FDA Link 09/2022
1	Carbon Tetrachloride (Tetrachloromethane)IBA 07/2022
1	Bile Acids and Salts (Bile Acids)IBA 07/2022
1	Collagen Type IV (Type IV Collagen)IBA 07/2022
1	Volatile Fatty AcidsIBA 07/2022
1	Collagen Type III (Type III Collagen)IBA 07/2022
1	Hyaluronic Acid (Hyaluronan)IBA 07/2022
1	Hydroxyproline (4 Hydroxyproline)IBA 07/2022
1	Laminin (Merosin)IBA 07/2022
1	Tight Junction ProteinsIBA 07/2022
1	tetramethylpyrazineIBA 06/2022
1	Thymidine Monophosphate (TMP)IBA 06/2022
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2022
1	ChlorophyllIBA 01/2022
1	N-methyladenosineIBA 01/2022
1	OsteocalcinIBA 01/2022
1	6-methyladenineIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 12/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2021
1	Sterol Regulatory Element Binding Protein 1IBA 05/2021
1	Sirtuin 1IBA 05/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2021
1	AMP-Activated Protein KinasesIBA 05/2021
1	LipidsIBA 05/2021
1	Transcription Factors (Transcription Factor)IBA 05/2021
1	EstersIBA 05/2021
1	ProdrugsIBA 05/2021
1	tocophersolanIBA 05/2021
1	2-chloroethyl methyl sulfideIBA 01/2021
1	Exenatide (Byetta)FDA Link 01/2021
1	Competitive Endogenous RNAIBA 01/2021

Therapy/Procedure

6	Therapeutics 12/2021 - 11/2009
5	Drug Therapy (Chemotherapy) 01/2022 - 11/2009
3	Neoadjuvant Therapy 11/2019 - 01/2017
3	Heavy Ion Radiotherapy 06/2019 - 01/2018
2	Precision Medicine 01/2022 - 01/2021
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 05/2021
1	Intraperitoneal Injections 07/2022